SCHEMBL6654101

SCHEMBL6654101

COc1cc(N)ccc1C(=O)c1ccccc1C

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.59
MAPK13 O15264 5/20 0.47
MAPK12 P53778 5/20 0.47
MAPK11 Q15759 5/20 0.47
MAPK14 Q16539 5/20 0.47
LMNA P02545 2/20 0.46
ALOX15 P16050 2/20 0.46
HSD17B10 Q99714 1/20 0.46
KCNK3 O14649 1/20 0.45
POLB P06746 1/20 0.45
KMT2A Q03164 1/20 0.45
KCNK9 Q9NPC2 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.44
CDC25B P30305 1/20 0.42
NPC1 O15118 1/20 0.42
CYP1A2 P05177 1/20 0.41
PGR P06401 1/20 0.41
CYP3A4 P08684 1/20 0.41
ADORA3 P0DMS8 1/20 0.41
AR P10275 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8000660 0.87 ALDH1A1 (0.76) ALDH1A1LMNAALOX15HSD17B10KMT2A
SCHEMBL15125786 0.83 NPC1 (0.62) ALDH1A1LMNAALOX15KMT2ASMN1; SMN2
SCHEMBL9177911 0.82 KCNK3 (0.56) LMNAALOX15HSD17B10KCNK3POLB
SCHEMBL29088629 0.81 ALDH1A1 (0.68) ALDH1A1MAPK14LMNAALOX15HSD17B10
SCHEMBL5174814 0.78 MAPK14 (0.49) ALDH1A1MAPK13MAPK12MAPK11MAPK14
SCHEMBL5172393 0.78 MAPK13 (0.61) ALDH1A1MAPK13MAPK12MAPK11MAPK14
SCHEMBL6653501 0.78 MAPK14 (0.77) ALDH1A1MAPK13MAPK12MAPK11MAPK14
SCHEMBL6652813 0.78 MAPK14 (0.64) ALDH1A1MAPK13MAPK12MAPK11MAPK14
SCHEMBL11003498 0.78 KMT2A (0.49) ALDH1A1MAPK13MAPK12MAPK11MAPK14
SCHEMBL10867573 0.78 ALDH1A1 (0.67) ALDH1A1LMNAHSD17B10POLBKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0966424-B1 AMINOBENZOPHENONES AS INHIBITORS OF INTERLEUKIN AND TNF LEO PHARMA AS (DK) 2004-06-23 EP disclosed
US-6313174-B1 FOR THERAPY AND PROPHYLAXIS OF ASTHMA, ALLERGY, RHEUMATOID ARTHRITIS, SPONDYLOARTHRITIS, GOUT, ATHEROSCLEROSIS, CHRONIC INFLAMMATORY BOWEL DISEASE, PROLIFERATIVE AND INFLAMMATORY SKIN DISORDERS Leo Pharmaceutical Products Ltd.A/S/ (Løvens kemiske Fabrik Produktionsaktieselskab) (DK) 2001-11-06 US disclosed
EP-0966424-A1 AMINOBENZOPHENONES AS INHIBITORS OF INTERLEUKIN AND TNF LEO PHARMACEUTICAL PRODUCTS LTD. A/S (LOVENS KEMISKE FABRIK PRODUKTIONSAKTIESELSKAB) (DK) 1999-12-29 EP disclosed
WO-1998032730-A1 AMINOBENZOPHENONES AS INHIBITORS OF INTERLEUKIN AND TNF Leo Pharmaceutical Products Ltd. A/S (Løvens Kemiske Fabrik Produktionsaktieselskab) (DK) 1998-07-30 WO disclosed